Chiffres clés du CRNL

Front News

Alzheimer : de nouveaux agents de contraste

Illustration article

Un consortium de chercheurs européens mené par plusieurs laboratoires lyonnais propose un nouvel agent d'imagerie « multi-techniques » (IRM, RX, fluorescence…) ciblant les plaques amyloïdes-β (Aβ), premiers signes pathologiques de la maladie d'Alzheimer (MA). Ces résultats sont parus dans la revue Nanomedecine.

Fabien Chauveau, équipe BIORAN, est co-auteur de cet article

© Prepared with authors’ own work, and additional material from SciDraw repository - modified from Wenbo Tang (doi: 10.5281/zenodo.3925923), Elisa Galliano (doi: 10.5281/zenodo.3926503), Agustin Carpaneto (doi: 10.5281/zenodo.3926119).

GENDEV publication!

PNAS

A collaborative team effort that combines clinical and new patient identification with cellular and zebrafish model analyses to establish the unsuspected link between minor splicing, a poorly known and under-studied mechanism, and the primary cilium. Hence, for the first time, a pathophysiological mechanism is discovered for these rare syndromes associated with RNU4ATAC.

Check the publication here.

All News →